AIM ImmunoTech Inc. — Director's Dealing 2012

Dec 21, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2012-12-19

Reporting Person: CARTER WILLIAM A (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-19	Common Stock	G	10000	—	Disposed	422423	Direct

Footnotes

F1: William A. Carter is gifting 10,000 shares to his brother, Robert E. Carter.